ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO712

Outcome and Prognostic Factors in ESRD Patients with Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Interventions

Session Information

Category: Hypertension and CVD

  • 1401 Hypertension and CVD: Epidemiology, Risk Factors, and Prevention

Authors

  • Ko, Byounghwi, Yonsei University College of Medicine, Seodaemungu, Seoul, Korea (the Republic of)
  • Jung, Chan-Young, Yonsei University College of Medicine, Seodaemungu, Seoul, Korea (the Republic of)
  • Jo, Wonji, Yonsei University College of Medicine, Seodaemungu, Seoul, Korea (the Republic of)
  • Joo, Youngu su, Yonsei University College of Medicine, Seodaemungu, Seoul, Korea (the Republic of)
  • Park, Jung Tak, Yonsei University College of Medicine, Seodaemungu, Seoul, Korea (the Republic of)
Background

Several risk factors have been recognized for acute coronary syndrome (ACS) undergoing percutaneous coronary interventions (PCI) in the general population. Risk factors for poor outcome in end stage renal disease (ESRD) patients differ from those who do not receive chronic dialysis. Although ESRD patients have been shown to be susceptible to cardiovascular diseases, the overall outcome and factors associated with prognosis is not well elucidated. Therefore, the characteristics and progress of ESRD patients who underwent PCI for ACS have been examined.

Methods

Retrospective analyses were conducted in ESRD patients who underwent PCI due to ACS from 1 January 2005 to 31 December 2018 at Yonsei University Health System, Seoul, South Korea. The patients were followed-up until 30th May, 2019. Demographic characteristics, laboratory parameter, echocardiographic findings, and dialysis related parameters at the time of PCI were collected.

Results

A total of 228 patients were included in the final analysis. The mean age was 66.9 ± 10.6 years, 146 (64.0 %) were male, and 82 (36.0 %) were being treated for diabetes. During a mean follow-up duration of 109.9 ± 94.8 months, 78 (34.2 %) cases of mortality were reported. When the patients were grouped into survivors and non-survivors, peripheral artery occlusive disease (PAOD) and left main coronary disease were more common among non-survivors. Echocardiographic ejection fraction (EF) and serum albumin levels were lower, while serum troponin T and CK-MB levels at the time of ACS were significantly higher among non-survivors. Multivariate logistic regression analysis revealed that concomitant PAOD (OR, 3.95; CI, 1.17-13.1), left main coronary disease (OR, 4.31; CI, 1.13-16.42), EF lower than 50% (OR, 8.30; CI, 1.84-37.41), lower serum albumin (OR, 4.29; CI, 1.44-12.79), and higher CK-MB (OR, 3.51; CI, 1.25-9.85) and troponin T levels (OR, 1.68; CI, 1.08-2.63) were significant factors related with in hospital mortality.

Conclusion

Outcome after PCI in ESRD patients with ACS was grave. Concomitant PAOD, echocardiographic findings, and cardiac enzyme levels could be practical factors predicting mortality in these patients.